WHO ICTRP trial
The effect of St John's Wort on pharmacokinetics and pharmacodynamics of…
ChiCTR-TRC-09000405 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-09000405 |
|---|---|
| Public title | The effect of St John's Wort on pharmacokinetics and pharmacodynamics of Repaglinide |
| Scientific title | The effect of St John's Wort on pharmacokinetics and pharmacodynamics of Repaglinide |
| Primary sponsor | Clinical Pharmacology Institute, Central South University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | healthy male |
| Interventions | experimental group:Repaglinide: 1mg/day; St John's Wort: 325mg 3 times a day*14 days. |
| Registration date | May 15, 2009 |
| Target size | experimental group:14 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: